Treatment of acquired amegakaryocytic thrombocytopenic purpura with romiplostim.
Department of Hematology, Tokushima Prefectural Central Hospital , Tokushima , Japan .
Toshio
T
Shigekiyo
Etsuko
E
Sekimoto
Hironobu
H
Shibata
Shuji
S
Ozaki
Hiroyuki
H
Fujinaga
Takanori
T
Hirose
D001855:Bone Marrow Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D011696:Purpura, Thrombocytopenic / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D011961:Receptors, Fc / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D013926:Thrombopoietin / Q000627:therapeutic use*
D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim
Acquired amegakaryocytic thrombocytopenic purpura; eltrombopag; romiplostim